Viewing Study NCT01345669

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 11:04 PM

Ignite Modification Date: 2025-12-25 @ 8:35 PM

Study NCT ID: NCT01345669

Status: TERMINATED

Last Update Posted: 2017-12-07

First Post: 2011-04-28

Is NOT Gene Therapy: False

Has Adverse Events: True

Brief Title: LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy

Sponsor: Boehringer Ingelheim

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module